Finance

Lists
Q2 2027 earnings
See results
524516:BOM
Bacil Pharma Ltd
21,41 ₹
-2,46%
(-0,54) 1D
16 հոկ, 15:57:51 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524516...
Open
20,86 ₹
High
21,95 ₹
Low
20,86 ₹
Mkt. cap
307,30 մլն
Avg. vol.
48,73 հզր
Volume
1,20 հզր
P/E ratio
38,42
52-wk high
61,80 ₹
52-wk low
10,65 ₹
EPS
0,56 ₹
No. of employees
2
Open
20,86 ₹
High
21,95 ₹
Low
20,86 ₹
Mkt. cap
307,30 մլն
Avg. vol.
48,73 հզր
Volume
1,20 հզր
P/E ratio
38,42
52-wk high
61,80 ₹
52-wk low
10,65 ₹
EPS
0,56 ₹
No. of employees
2
News stories
From web sources and news partners
About Bacil Pharma Ltd
CEO-
Employees2
Founded1987
Headquarters-
Sector-
Last report
14 հոկ, 2026 թ.
Fiscal period
Q2 2027
- / -
Revenue / Est. (INR)
918,00 հզր / -
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
-
-
-
918,00 հզր
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
60,00 հզր
109,00 հզր
72,00 հզր
72,00 հզր
Operating expense
253,00 հզր
743,00 հզր
227,00 հզր
593,00 հզր
Total operating expenses
253,00 հզր
743,00 հզր
227,00 հզր
593,00 հզր
Operating income
-253,00 հզր
-743,00 հզր
-227,00 հզր
325,00 հզր
Other non operating income
645,00 հզր
-1,22 մլն
891,00 հզր
-
EBT including unusual items
392,00 հզր
390,00 հզր
664,00 հզր
-299,00 հզր
EBT excluding unusual items
392,00 հզր
390,00 հզր
664,00 հզր
-299,00 հզր
Income tax expense
-
-7,95 մլն
825,00 հզր
423,00 հզր
Effective tax rate
-
-2 037,95%
124,25%
-141,47%
Other operating expenses
193,00 հզր
634,00 հզր
155,00 հզր
521,00 հզր
Net income
392,00 հզր
8,34 մլն
-161,00 հզր
-722,00 հզր
Net profit margin
-
-
-
-78,65%
Earnings per share
-
-
-
-
Interest and investment income
-
2,35 մլն
-
-
Interest expense
-
-
-
-624,00 հզր
Net interest expenses
-
2,35 մլն
-
-624,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-251,25 հզր
-741,25 հզր
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps